Wapnick Pamela

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 8% 8.2% 15.1%
Success rate 87% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Wapnick Pamela's trades of Metagenomi Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-10 2026-09-08
S Sale
43,403 +42.9%
133.90
US$627,077 		43,403 +42.9% 133.90 US$627,077
2026-09-10 2026-09-08
S Sale
30,721 -41.8%
27.28
US$929,745 		30,721 -41.8% 27.28 US$929,745
2026-06-10 2026-06-05
S Sale
92,315 +28.4%
416.12
US$2,658,509 		92,315 +28.4% 416.12 US$2,658,509
2026-03-09 2026-03-05
S Sale
1,581 -0.8%
1.60
US$2,530 		1,581 -0.8% 1.60 US$2,530
2025-12-08 2025-12-05
S Sale
1,576 -0.8%
1.77
US$2,793 		1,576 -0.8% 1.77 US$2,793
2025-12-01 2025-09-05
S Sale
1,576 -2.2%
1.81
US$2,853 		1,576 -2.2% 1.81 US$2,853
2025-06-09 2025-06-06
S Sale
1,576 -2.1%
1.75
US$2,758 		1,576 -2.1% 1.75 US$2,758
2025-03-07 2025-03-05
S Sale
1,808 -2.9%
1.87
US$3,390 		1,808 -2.9% 1.87 US$3,390
2024-12-06 2024-12-05
S Sale
1,559 -2.5%
1.86
US$2,900 		1,559 -2.5% 1.86 US$2,900
2024-09-06 2024-09-05
S Sale
6,265 -9.0%
2.88
US$18,043 		6,265 -9.0% 2.88 US$18,043